Kuros Biosciences AG
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Kuros Biosciences AG's past years’ income statements indicate that its last revenue has increased compared to the previous period by 87% to $33,564,000. The net income raised on -$13,727,000 and profit margin reached -41%. Total operating expenses were $37,128,000.

Profit Margin

Kuros Biosciences AG (SIX:KURN.SW): Profit margin
2014 1M -34.02M -3402.6%
2015 6.35M 6.22M 97.99%
2016 1.06M -19.74M -1860.89%
2017 534K -16.48M -3086.89%
2018 715K -11.69M -1635.38%
2019 2.56M -11.25M -439.36%
2020 4.03M -11.52M -285.22%
2021 13.81M -7.54M -54.59%
2022 17.98M -14.59M -81.15%
2023 33.56M -13.72M -40.9%

KURN.SW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
33.56M17.98M13.81M4.03M2.56M715K534K1.06M6.35M1M
Cost of revenue
9.62M7.21M3.74M2.36M2.64M3.41M3.30M0563K10.10M
Gross profit
23.93M10.76M10.06M1.67M-79K-2.70M-2.77M1.06M5.79M-9.10M
Operating exp.
Research and development
5.59M5.19M4.98M4.00M6.47M04.47M7.90M1.08M17.47M
Selling and marketing
17.13M8.08M4.79M1.55M2.30M00046K202K
Total operating expenses
37.12M24.21M18.83M13.35M11.31M11.02M11.27M22.40M5.13M9.83M
Operating income
-13.19M-13.44M-8.76M-11.67M-11.39M-13.72M-16.24M-21.34M654K-18.93M
Other income (expenses), net
-155K-2.54M-787K-415K-431K-86K-350.00K1.04M-1.60M-15.08M
Income before tax
-13.34M-15.99M-9.55M-12.09M-11.82M-13.81M-16.59M-20.27M6.22M-34.02M
Income tax expense
380K-1.39M-2.01M-574K-571K-2.12M-109K-533K-46K200K
Net income
-13.72M-14.59M-7.54M-11.52M-11.25M-11.69M-16.48M-19.74M6.22M-34.02M
Earnings per share
Basic EPS
-0.38-0.43-0.23-0.47-0.66-1.14-1.88-3.19-226.97-96.7
Diluted EPS
-0.38-0.43-0.23-0.47-0.66-1.14-1.88-3.19-226.97-96.7
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source